Lexington, KY – July 31, 2014

Omega Ophthalmics LLC (Omega) has announced today that Ike K. Ahmed, M.D. has joined their Medical Advisory Board, effective immediately.

Ike K. Ahmed, MD is a fellowship-trained glaucoma, cataract, and anterior segment surgeon with a practice focus on the surgical management of glaucoma, complex cataract and intraocular lens complications. He is board-certified in ophthalmology in Canada and the USA, and is an active member of the Canadian Ophthalmological Society (COS), American Academy of Ophthalmology (AAO), American Society of Cataract and Refractive Surgery (ASCRS), Association for Vision and Research in Ophthalmology (ARVO), International Society of Glaucoma Surgery (ISGS), Canadian Glaucoma Society (CGS), and the American Glaucoma Society (AGS).

“We are so pleased to welcome Dr. Ahmed to our Medical Advisory Board. Ike is a world-class innovator and surgeon,” said Gary Wörtz, MD, Omega’s Chief Medical Officer.

Dr. Ahmed has become world renowned for his skills and groundbreaking work in the diagnosis and surgical treatment of highly complex eye diseases including glaucoma and surgical complications. He has been at the leading edge of novel treatments for cataract surgery and the new category of micro-invasive glaucoma surgery (MIGS) implants.

He is currently an Assistant Professor at the University of Toronto, and a Clinical Assistant Professor at the University of Utah. He is the Research Fellowship Director, Department of Ophthalmology, University of Toronto, and is the Director of the Glaucoma and Advanced Anterior Surgical (GAASS) fellowship at the University of Toronto.

---

About Omega Ophthalmics

Omega Ophthalmics is a medical device company making significant advancements in the global ophthalmology industry through its patent-pending, proprietary technologies for intraocular lenses, capsular bags, and high technology applications within the eye. Founded by Gary Wörtz, MD and Rick Ifland, Omega is headquartered in Lexington, KY.

For more information about Omega Ophthalmics, contact Rick Ifland, CEO.

For more information about Omega's technology, contact Gary Wörtz, MD, CMO.